SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

VIVAS, Dan; INGA, Rosío  and  YARLEQUE, Armando. Uso potencial de componentes del veneno de serpiente en el tratamiento del cáncer. Rev Peru Med Exp Salud Publica [online]. 2012, vol.29, n.3, pp.396-401. ISSN 1726-4642.

    1. Carmeliet P. Angiogenesis in life, desease and medicine. Nature. 2005;438(7070):932-6. [ Links ]

    2. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Med. 2003;9(6):669-76. [ Links ]

    3. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005;438(7070):967-74. [ Links ]

    4. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 2004;25(4): 581-611. [ Links ]

    5. McColl BK, Stacker SA, Achen MG. Molecular regulation of the VEGF -- family inducers of angiogenesis and lymph angiogenesis. APMIS. 2004;112(7-8):463-80. [ Links ]

    6. Swenson S, Ramu S, Markland FS. Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr Pharm Des. 2007;13(28):2860-71. [ Links ]

    7. Fraga A, Ribeiro R, Medeiros R. Hipoxia tumoral. Papel del factor inducible por hipoxia. Actas Urol Esp. 2009;33(9):941-51. [ Links ]

    8. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Peer J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155(3):739-52. [ Links ]

    9. Chiang AC, Massagu J. Molecular basis of metastasis. N Engl J Med. 2008;359(26):2814-23. [ Links ]

    10. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39(3):305-18. [ Links ]

    11. Kawaguchi T. Cancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5(1):39-64. [ Links ]

    12. Barreiro O, Snchez-Madrid F. Bases moleculares de las interacciones leucocito-endotelio durante la respuesta inflamatoria. Rev Esp Cardiol. 2009;62(5):552-62. [ Links ]

    13. Nemeth JA, Nakada MT, Trikha M, Lang Z, Gordon MS, Jayson GC, et al. Alpha-v integrins as therapeutic targets in oncology. Cancer Invest. 2007;25(7):632-46. [ Links ]

    14. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002;2(2):91-100. [ Links ]

    15. McLane MA, Joerger T, Mahmoud A. Disintegrins in health and disease. Front Biosci. 2008;13:6617-37. [ Links ]

    16. Calvete JJ, Marcinkiewicz C, Monlen D, Esteve V, Celda B, Jurez P, et al. Snake venom disintegrins: evolution of structure and function. Toxicon. 2005;45(8):1063-74. [ Links ]

    17. Koh DC, Armugam A, Jeyaseelan K. Snake venom components and their applications in biomedicine. Cell Mol Life Sci. 2006;63(24):3030-41. [ Links ]

    18. Sheu JR, Yen MH, Kan YC, Hung WC, Chang PT, Luk HN. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody. Biochim Biophys Acta; 1997;1336(3):445-54. [ Links ]

    19. Minea R, Swenson S, Costa F, Chen TC, Markland FS. Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophysiol Haemost Thromb. 2005;34(4-5):177-83. [ Links ]

    20. Miltyk W, Surazyński A, Sławomir W, Pałka JA. Combined therapy with disintegrin and melphalan as a new strategy in inhibition of endometrial cancer cell line (Ishikawa) growth. Folia Histochem Cytobiol. 2009;47(5):S121-5. [ Links ]

    21. Jang YJ, Kim DS, Jeon OH, Kim DS. Saxatilin suppresses tumor-induced angiogenesis by regulating VEGF expression in NCI-H460 human lung cancer cells. J Biochem Mol Biol. 2007;40(3):439-43. [ Links ]

    22. Brown MC, Staniszewska I, Del Valle L, Tuszynski GP, Marcinkiewicz C. Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth. Int J Cancer. 2008;123(9):2195-203. [ Links ]

    23. Chung KH, Kim SH, Han KY, Sohn YD, Chang SI, Baek KH, et al. Inhibitory effect of salmosin, a Korean snake venom-derived disintegrin, on the integrin alphav-mediated proliferation of SK-Mel-2 human melanoma cells. J Pharm Pharmacol. 2003;55(11):1577-82. [ Links ]

    24. Ramos OH, Kauskot A, Cominetti MR, Bechyne I, Salla Pontes CL, Chareyre F, et al. A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis. Clin Exp Metastasis. 2008;25(1):53-64. [ Links ]

    25. Ren A, Wang S, Cai W, Yang G, Zhu Y, Wu X, Zhang Y. Agkistin-s, a disintegrin domain, inhibits angiogenesis and induces BAECs apoptosis. J Cell Biochem. 2006;99(6):1517-23. [ Links ]

    26. Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, et al. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther. 2004;3(4):499-511. [ Links ]

    27. Kim SI, Kim KS, Kim HS, Kim DS, Jang Y, Chung KH, et al. Inhibitory effect of the salmosin gene transferred by cationic liposomes on the progression of B16BL6 tumors. Cancer Res. 2003;63(19):6458-62. [ Links ]

    28. Kohlhoff M, Borges M, Yarleque A, Cabezas C, Richardson M, Sanchez E. Exploring the proteomes of the venoms of the Peruvian pit-vipers Bothrops atrox, B. barnetti and B. pictus. J Proteomics. 2012;75:2181-95. [ Links ]